baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Goldman Sachs Knock-Out PGR/ DE000GQ7Q402 /

5/23/2024 9:53:22 PM	Chg.-0.32	Bid10:00:39 PM	Ask10:00:39 PM	Underlying	Strike price	Expiration date	Option type
4.82EUR	-6.23%	- Bid Size: -	- Ask Size: -	Progressive Corporat...	152.1278 USD	12/31/2078	Call

GlobeNewswire 5/23 Compass Therapeutics to Present Phase 1 Data for CTX-471, A Novel CD137 Agonist Antibody, Demonstrat...

GlobeNewswire 5/23 Merus Announces Publication of an Abstract on Petosemtamab with Pembrolizumab as 1L treatment of r/m...

GlobeNewswire 5/23 Candel Therapeutics Reports Prolonged Overall Survival in Phase 2 Clinical Trial of CAN-2409 for Adv...

GlobeNewswire 5/23 Theriva™ Biologics Announces Fast Track Designation Granted by the U.S. FDA for VCN-01 for the Treat...

GlobeNewswire 5/23 Pinellas REALTOR Organization/Central Pasco REALTOR Organization and Greater Tampa REALTORS Approve ...

GlobeNewswire 5/23 Award-Winning Food Tour Company, Flavors Food Tours, Launches In Savannah

GlobeNewswire 5/21 Sana Biotechnology Highlights Publication in Nature Biotechnology of Novel In Vivo Preclinical Data ...

GlobeNewswire 5/20 Avalyn Presents Clinical Data on AP01 for Pulmonary Fibrosis, Including Long-Term Efficacy and Imagi...

TeleTrader 5/20 Yellen says US against tax on billionaires

GlobeNewswire 5/20 APRINOIA Therapeutics Announces Fast Track Designation Granted by U.S. FDA to APN-1607 (florzolotau)...

GlobeNewswire 5/20 Dyne Therapeutics Announces New Clinical Data from ACHIEVE Trial of DYNE-101 in DM1 and DELIVER Tria...

GlobeNewswire 5/20 MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Preventio...

GlobeNewswire 5/16 BMW unveils The BMW XM Mystique Allure, a one-of-a-kind luxury vehicle inspired by the iconic superm...

GlobeNewswire 5/15 Eyenovia Reports First Quarter 2024 Financial Results and Provides Updates on its Myopia Phase III P...

TeleTrader 5/15 Slovakian opposition denies connection to Fico's attack

GlobeNewswire 5/15 Progressive Reports April 2024 Results

GlobeNewswire 5/14 MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Treatment...

GlobeNewswire 5/13 Avalyn Announces Multiple Presentations on its Lead Program, AP01, for Pulmonary Fibrosis and its Ap...

GlobeNewswire 5/13 BridgeBio Pharma Presents Additional Data and Analyses from its Phase 3 ATTRibute-CM Study in Transt...

GlobeNewswire 5/13 Fulcrum Therapeutics Enters into a Collaboration and License Agreement with Sanofi for the Developme...

GlobeNewswire 5/9 Travere Therapeutics to Present at National Kidney Foundation Spring Clinical Meetings and the 61st ...

GlobeNewswire 5/9 Freeline Presents Positive New Data from Phase 1/2 Trial of FLT201, Its Novel Gene Therapy Candidate...

GlobeNewswire 5/8 Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Plan...

GlobeNewswire 5/7 MediciNova Receives Issue Notification for New Patent Covering Extended-Release Formulations of MN-1...

GlobeNewswire 5/6 Belite Bio Presents Additional Analysis from Phase 2 Study of Tinlarebant in Stargardt Disease at th...

Goldman Sachs Knock-Out PGR/ DE000GQ7Q402 /

If you wish to receive reply to your feedback, please provide your email address.